The objective of this study was to evaluate the effect of digestible methionine and cystine (Met + Cys) levels on the hematological and serum biochemical parameters of broiler chickens during the initial and growth stages. For this, 1,800 male chicks of the Coob 500 strain were used, with 900 chicks in the initial phase (1 to 21 days old) and 900 chicks in the growth phase (22 to 42 days old), distributed in a completely randomized design of five treatments with six replicates of 30 birds. The treatments consisted of 0.545, 0.616, 0.711, 0.782, and 0.853%; and 0.514, 0.571, 0.647, 0.704, and 0.761% digestible Met + Cys for “1 to 21” and “22 to 42” days of breeding, respectively. Results showed that digestible Met + Cys levels in broiler feed altered some hematological parameters (erythrocyte, hematocrit hemoglobin, total leukocytes, heterophile: lymphocyte) and serum biochemistry (uric acid, PST, total LDL, and TG). The digestible Met + Cys levels in the diet of broilers affected the hematological parameters and serum biochemistry, especially at higher levels. From the inclusion level 0.761 of Met + Cist in the broiler diet, red blood cells, hemoglobin and hematocrit changes begin to appear.
This study aimed to evaluate the immunity of chickens up to 35 d subjected to posthatch fasting and supplementation with conjugated linoleic acid (CLA). A total of 320 chicks were housed in a completely randomized design with a 2 pound 2 factorial arrangement (0 or 12 h of fasting pound 0.000 or 0.025% CLA in a prestarter diet), totaling 4 treatments (No -F12 h; F-12 h; No-CLA; CLA) with 8 replicates of 10 birds each. The relative weights (% body weight) of the spleen and bursa were determined 12 h posthatch (Post -12 h) and then weekly. Immunoglobulin Y (IgY) titers against Newcastle disease virus (NDV) were measured by ELISA in the yolk sac contents Post-12 h and in the serum weekly. Hypersensitivity to phytohemagglutinin (PHA) inoculation was evaluated by toe-web swelling response on d 13 and 34, 4 times a day (after 3 h, 6 h, 12 h, and 24 h inoculation, respectively, PHA-3 h, PHA-6 h, PHA-12 h, and PHA-24 h). The data were subjected to analysis of variance (P < 0.05). F-12h reduced the Post-12 h relative weight of the spleen, and CLA reduced the relative weight of the bursa at this stage and at 28 d. At 13 d, F-12 h reduced PHA-3 h, whereas PHA-12 h was increased by CLA. At 34 d, CLA reduced PHA-3 h. A greater reaction was observed in the No-F-12 h-CLA chicks, for the PHA-24 h. In the Post-12 h evaluation, F-12h reduced, whereas CLA increased NDV-specific IgY titers in the yolk sac. No-F-12 h-No-CLA chicks had the lowest serum titers. At 21 d, F-12 h-CLA chicks exhibited the highest serum titers. Titers were higher in the F-12 h-No-CLA chicks, when compared to other treatments. At 28 d, fasting reduced the titers. In conclusion, F-12 h and CLA accelerated the transfer of immunoglobulins from the yolk sac to the serum. F-12 h impairs cellular immunity, whereas CLA favors it.
1 January 2017 in Revista Colombiana de Ciencias Pecuarias
Conjugated linoleic acid (CLA) refers to a group of positional and geometric isomers of linoleic acid. Hens fed a diet supplemented with CLA exhibit increased levels of saturated fatty acids, which may influence the quality characteristics of eggs and the offspring lipid metabolism. The present study, aimed to evaluate the effect of the dietary inclusion of CLA for broiler breeders on the residual yolk sac fatty acid profile, egg quality, and hatchability. Two 58-week-old Cobb500® broiler breeder commercial flocks were fed diets supplemented with 0% or 0.025% CLA (trans-10, cis-12). After 26 days, 300 eggs from each treatment group were collected, and among these eggs, 30 were subjected to egg quality assessment and egg yolk fatty acid profile analysis. The remaining 270 eggs were subjected to incubation analysis. The quality of the chicks was evaluated at hatch. The residual yolk sac content and weight at hatch were also evaluated. Unhatched eggs were subjected to residual analysis. The supplementation of the breeders’ diet with 0.025% CLA did not influence the incubation parameters and the weight of the chicks at hatch. However, the egg yolk and residual yolk sac fatty acid profile were altered and CLA accumulation was increased in the residual yolk sac at hatch in this treatment group. In conclusion, CLA supplementation in the diet of breeders did not influence the incubation parameters and the weight of the chicks, although it did alter the profiles of omega-6, palmitoleic, linoleic, and arachidonic acids in both egg yolk and residual yolk sac.
5 December 2025 in Revista Brasileira de Zootecnia
A raiva é uma encefalite progressiva e zoonótica, capaz de afetar todos os mamíferos, e apresenta alta taxa de letalidade. A transmissão do vírus ocorre por meio de mordeduras, arranhaduras e lambeduras de animais infectados. O atendimento de profilaxia pós exposição ao vírus rábico, proporciona medidas preventivas essenciais para evitar desenvolvimento da enfermidade em humanos. Dada a relevância deste atendimento, o objetivo deste estudo é caracterizar os animais envolvidos nos atendimentos de profilaxia antirrábica humana no município de Jataí, Goiás, entre os anos de 2015 e 2019. Para isso, foram analisados dados registrados no Sistema de Informação de Agravos de Notificação (SINAN) do Ministério da Saúde. As análises foram realizadas com o auxílio do software Microsoft Excel 2010®.Durante o período estudado, foram registradas 2.453 notificações, das quais 82,4% eram de animais da espécie canina. Em 77% dos casos, os animais estavam aparentemente saudáveis, e em 76,7% dos atendimentos, cães e gatos foram colocados sob observação. Ao final do período de observação, 69,5% dos animais não apresentaram sinais clínicos compatíveis com raiva. O tratamento mais comum adotado no município foi a observação, acompanhada de vacinação, em 69% dos casos. Dada a gravidade da enfermidade, é fundamental que a descrição do agravo na ficha, e a recomendação de profilaxia sejam prescritas de maneira correta. Estas garantem a eficácia de prevenção à doença, e eficácia do tratamento quando necessário.